Home > Cardiology > ESC 2020 > COVID and Cardiovascular Disease > Risk factors for thromboembolism and bleeding in COVID-19: lessons from Wuhan

Risk factors for thromboembolism and bleeding in COVID-19: lessons from Wuhan

Presented By
Prof. Yutao Guo , Chinese PLA General Hospital, China
Conference
ESC 2020
An evaluation of patients with COVID-19 who were admitted to the hospital in Wuhan, China, showed that they were at high risk for thromboembolic and bleeding events, as well as mortality [1]. Anticoagulant use, especially use of parenteral anticoagulants, significantly reduced the risk of the composite outcome of thromboembolism, bleeding events, and death. The presence of atrial fibrillation (AF) was a contributor to systemic thromboembolism in COVID-19 patients. COVID-19 is associated with a high risk of thrombotic complications, which contribute to the high mortality rate. Limited data is yet available on systemic thromboembolism and the value of anticoagulation regimens. Prof. Yutao Guo (Chinese PLA General Hospital, China) presented the study that investigated the prevalence of systemic and venous thromboembolism, as well as major bleeding and mortality, in relation to underlying risk factors and the impact of anticoagulation use in hospitalised pati...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on